Genetic engineering of Streptococcus gordonii for the simultaneous display of two heterologous proteins at the bacterial surface

FEMS Microbiology Letters

Volumn 210, Issue 1, 2002, Pages 135-141

  Maggi, Tiziana ^a   Spinosa, Maria ^a   Ricci, Susanna ^a   Medaglini, Donata ^a   Pozzi, Gianni ^a   Oggioni, Marco R ^a  

^a UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; CELL SURFACE PROTEIN; ESCHERICHIA COLI ENDOTOXIN; GLYCOPROTEIN GP 120; IMMUNOGLOBULIN G; MONOMER;

ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERIAL CELL; BACTERIAL STRAIN; CELL SURFACE; CONTROLLED STUDY; ESCHERICHIA COLI; EXPRESSION VECTOR; FEMALE; GENE CONSTRUCT; GENETIC ENGINEERING; GENETIC RECOMBINATION; GENETIC STABILITY; HETEROLOGOUS EXPRESSION; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNIZATION; IMMUNOMODULATION; INOCULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; STREPTOCOCCUS GORDONII;

ANIMALS; BACTERIAL PROTEINS; BACTERIAL TOXINS; CELL MEMBRANE; COLONY-FORMING UNITS ASSAY; ENTEROTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; GENETIC ENGINEERING; GENETIC MARKERS; HIV ENVELOPE PROTEIN GP120; HIV-1; MICE; MICE, INBRED BALB C; RECOMBINATION, GENETIC; STREPTOCOCCUS;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; HUMAN IMMUNODEFICIENCY VIRUS 1; POSIBACTERIA; STREPTOCOCCUS; STREPTOCOCCUS GORDONII;

EID: 0037161212     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1097(02)00610-9     Document Type: Article

References (38)

1. Bacterial surface display: Trends and progress
2. Therapy of mucosal candidiasis by expression of an anti-idiotype in human commensal bacteria
3. Treatment of murine colitis by Lactococcus lactis secreting Interleukin-10
4. Demonstration of safety of probiotics - a review
5. Recombinant Streptococcus gordonii as live vehicle for vaccine antigens
6. Oral vaccination of mice against tetanus with recombinant Lactococcus lactis
7. Development of nonpathogenic staphylococci as vaccine delivery vehicles
8. Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: A candidate Lyme disease vaccine
9. Attenauted Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coli
10. Expression of functional Porphyromonas gingivalis fimbrillin polypeptide domains on the surface of Streptococcus gordonii
11. A surface-displayed cholera toxin B peptide improves antibody responses using food-grade staphylococci for mucosal subunit vaccine delivery
12. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2
13. DNA vaccination using coexpression of cytokine genes with a bacterial gene encoding a 60-kDa heat shock protein
14. Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of lactococcus lactis coexpressing antigen and cytokine
15. A host-vector system for heterologous gene expression in Streptococcus gordonii
16. Engineering the Gram-positive cell surface for construction of bacterial vaccine vectors
17. Antigenicity and immunogenicity of the V3 domain of HIV-1 gp120 expression on the surface of Streptococcus gordonii
18. Immunogenicity of the B monomer of Escherichia coli heat-labile toxin expressed on the surface of Streptococcus gordonii
19. Commensal bacteria as vehicles for mucosal vaccines against sexually transmitted diseases: Vaginal colonisation with recombinant streptococci includes local and systemic antibodies in mice
20. Insertion of a HIV-1-neutralizing epitope in a surface-exposed internal region of the cholera toxin B-subunit
21. Intranasal immunization with recombinant group A streptococcal M protein fragment fused to the B subunit of Escherichia coli labile toxin protects mice against systemic challenge infections
22. Current progress in the development of the B subunits of cholera toxin and Escherichia coli heat-labile enterotoxin as carriers for the oral delivery of heterologous antigens and epitopes
23. Oral immunization with the saliva-binding region of Streptococcus mutans AgI/II genetically coupled to the cholera toxin B subunit elicits T-helper-cell responses in gut-associated lymphoid tissues
24. Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins
25. Immune modulation by the cholera-like enterotoxins: From adjuvant to therapeutic
26. Method and parameters for genetic transformation of Streptococcus sanguis Challis
27. Human T-helper cell recognition of an immunodominant epitope of HIV-1 gp120 expressed on the surface of Streptococcus gordonii
28. Production of site-selected neutralizing human monoclonal antibodies against the third variable domain of the human immunodeficiency virus type 1 envelope glycoprotein
29. Studies on the genomic organization of recombinant Streptococcus gordonii and the development of a novel intergenic integration site fot foreign gene expression
30. Expression of M6 protein gene of Streptococcus pyogenes in Streptococcus gordonii after chromosomal integration and transcriptional fusion
31. Human dendritic cells very efficiently present a heterologous antigen expressed on the surface of recombinant Gram-positive bacteria to CD4+ T lymphocytes
32. Bacterial-induced neo-biosynthesis, stabilization and surface expression of functional class I molecules in mouse dendritic cells
33. Human dendritic cells are superior to B cells at presenting a major histocompatibility complex class-II restricted heterologous antigen expressed on recombinant Streptococcus gordonii
34. Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming
35. Surface co-expression of Vibrio cholerae and Salmonella typhi O-antigens on Ty21a clone EX210
36. Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: High-level production of virus-like particles containing HIV envelope